Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Change in Receivables (2016 - 2021)

Medifast (MED) has disclosed Change in Receivables for 12 consecutive years, with -$496000.0 as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Change in Receivables rose 52.63% year-over-year to -$496000.0, compared with a TTM value of $254000.0 through Mar 2021, down 92.52%, and an annual FY2020 reading of -$297000.0, down 107.31% over the prior year.
  • Change in Receivables was -$496000.0 for Q1 2021 at Medifast, down from -$15000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $3.7 million in Q3 2019 and bottomed at -$1.0 million in Q1 2020.
  • Average Change in Receivables over 5 years is $208411.8, with a median of $19000.0 recorded in 2017.
  • The sharpest move saw Change in Receivables surged 2057.89% in 2018, then plummeted 251.85% in 2019.
  • Year by year, Change in Receivables stood at $19000.0 in 2017, then soared by 2057.89% to $410000.0 in 2018, then increased by 1.22% to $415000.0 in 2019, then plummeted by 103.61% to -$15000.0 in 2020, then crashed by 3206.67% to -$496000.0 in 2021.
  • Business Quant data shows Change in Receivables for MED at -$496000.0 in Q1 2021, -$15000.0 in Q4 2020, and $319000.0 in Q3 2020.